Intravenous Autologous Mesenchymal Stem Cells Transplantation to Treat Middle Cerebral Artery Infarct

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01461720
Recruitment Status : Unknown
Verified March 2015 by Dr Norlinah Mohamed Ibrahim, National University of Malaysia.
Recruitment status was:  Recruiting
First Posted : October 28, 2011
Last Update Posted : April 1, 2015
Cytopeutics Sdn Bhd
Information provided by (Responsible Party):
Dr Norlinah Mohamed Ibrahim, National University of Malaysia

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : December 2015
  Estimated Study Completion Date : March 2016